Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
9 Months Ended
Jan. 31, 2019
Mar. 14, 2019
Document And Entity Information [Abstract]    
Entity Registrant Name PharmaCyte Biotech, Inc.  
Entity Central Index Key 0001157075  
Document Type 10-Q  
Document Period End Date Jan. 31, 2019  
Amendment Flag false  
Current Fiscal Year End Date --04-30  
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   1,126,904,505
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019